arly-and Long-Term Intravascular ltrasound and Angiographic Findings fter Bioabsorbable Magnesium Stent mplantation in Human Coronary Arteries on

on Waksman, MD,* Raimund Erbel, MD,† Carlo Di Mario, MD,‡ ozef Bartunek, MD,§ Bernard de Bruyne, MD,§ Franz R. Eberli, MD, Paul Erne, MD,¶ ichael Haude, MD, MS,† Mark Horrigan, MD,** Charles Ilsley, MD,‡ Dirk Böse, MD,† ans Bonnier, MD,# Jacques Koolen, MD,# Thomas F. Lüscher, MD, eil J. Weissman, MD,* on behalf of the PROGRESS-AMS (Clinical Performance and ngiographic Results of Coronary Stenting with Absorbable Metal Stents) Investigators

[1]  Patrick W Serruys,et al.  A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial , 2008, The Lancet.

[2]  K. Waldmann,et al.  Efficacy and safety of absorbable metallic stents with adjunct intracoronary beta radiation in porcine coronary arteries. , 2007, Journal of interventional cardiology.

[3]  Raimund Erbel,et al.  Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial , 2007, The Lancet.

[4]  P. Serruys,et al.  Two-year serial coronary angiographic and intravascular ultrasound analysis of in-stent angiographic late lumen loss and ultrasonic neointimal volume from the TAXUS II trial. , 2007, The American journal of cardiology.

[5]  M. Briel,et al.  Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis. , 2006, European heart journal.

[6]  Karl-Heinz Waldmann,et al.  Safety and efficacy of bioabsorbable magnesium alloy stents in porcine coronary arteries , 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[7]  Michael Joner,et al.  Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. , 2006, Journal of the American College of Cardiology.

[8]  J. Carr,et al.  Quantitative assessment of in‐stent dimensions: A comparison of 64 and 16 detector multislice computed tomography to intravascular ultrasound , 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[9]  Matthew H Samore,et al.  Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. , 2006, Journal of the American College of Cardiology.

[10]  P. Serruys,et al.  Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation. , 2006, European heart journal.

[11]  Jan J Piek,et al.  A randomized comparison of a durable polymer Everolimus-eluting stent with a bare metal coronary stent: The SPIRIT first trial. , 2005, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[12]  G. Stone,et al.  Polymer-based paclitaxel-eluting stents reduce in-stent neointimal tissue proliferation: a serial volumetric intravascular ultrasound analysis from the TAXUS-IV trial. , 2005, Journal of the American College of Cardiology.

[13]  P. Serruys,et al.  Maintenance of Long-Term Clinical Benefit With Sirolimus-Eluting Coronary Stents: Three-Year Results of the RAVEL Trial , 2005, Circulation.

[14]  Bernd Heublein,et al.  Preliminary Results after Application of Absorbable Metal Stents in Patients with Critical Limb Ischemia , 2005, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[15]  H. Eggebrecht,et al.  Images in cardiology: the invisible stent: imaging of an absorbable metal stent with multislice spiral computed tomography. , 2005, Heart.

[16]  Raimund Erbel,et al.  Drug-eluting bioabsorbable magnesium stent. , 2004, Journal of interventional cardiology.

[17]  Jeffrey W Moses,et al.  Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. , 2003, The New England journal of medicine.

[18]  N. Weissman,et al.  Regional Remodeling as the Cause of Late Stent Malapposition , 2003, Circulation.

[19]  A Haverich,et al.  Left main coronary artery fistula exiting into the right atrium , 2003, Heart.

[20]  Mary E. Russell,et al.  TAXUS I: Six- and Twelve-Month Results From a Randomized, Double-Blind Trial on a Slow-Release Paclitaxel-Eluting Stent for De Novo Coronary Lesions , 2003, Circulation.

[21]  C. Tracy,et al.  American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. , 2001, Journal of the American College of Cardiology.

[22]  A. Colombo,et al.  Results of coronary stenting for restenosis. , 1996, Journal of the American College of Cardiology.

[23]  W Rutsch,et al.  A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. , 1994, The New England journal of medicine.

[24]  Julio C. Palmaz,et al.  Clinical Experience With the Palmaz‐Schatz Coronary Stent: Initial Results of a Multicenter Study , 1991, Circulation.

[25]  F Joffre,et al.  Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. , 1987, The New England journal of medicine.